health ๐ฌ Most HIV patients prefer long-acting treatment
A systematic review and meta-analysis published in the journal AIDS found that over two-thirds of people on daily HIV pills are willing to switch to long-acting regimens. This willingness varied across studies, which were mostly conducted in high-income countries. The review authors stressed that individuals should be informed about this option when clinically and contextually appropriate. This shift could significantly improve treatment adherence for people living with HIV. Further research is needed to better understand these individualized treatment preferences.